Skip to main content
. 2017 Dec 5;8(70):115754–115773. doi: 10.18632/oncotarget.22975

Table 4. Hypoxia-deregulated miRNAs in NSCLCs.

miRNA Target genes Correlationwith HIF-1α Entity (regulation under HOX) Main function of miRNA Reference
miR-15a n. d. neg. NSCLC (down) n. d., miR-15a expression negatively correlates with HIF-1α [132]
miR17-92 cl. HIF-1α neg. Lung cancer (up) Mediate HIF-1α inhibition of cell growth in normoxic conditions [133]
miR-21 HIF-1α pos. Adenocarcinoma and radioresistant NSCLC (up) Influences cancer cell adaptation to tumor-specific environment, promotes glycolysis and modulates radioresistance by upregulation of HIF-1α [134136]
miR-23a PHD1, PHD2, ZO-1 pos. Adenocarcinoma (up) Enhances neovascularization and tumor growth [137]
miR-101 Cox2, Lin28B, let-7 miRNA neg. NSCLC (down) Tumor suppressive function in NSCLC [138]
miR-143 IGF-IR, IRS1 neg. Cr (VI)-transformed lung epithelial cells (down) Antiangiogenic effects [139]
miR-155 FOXO3A, TP53INP1 pos. NSCLC (up) Shows radio-protective effect in NSCLC cell lines [140]
miR-191 NF1A pos. NSCLC (up) Promotes cell proliferation and migration under HOX [141]
miR-199a HIF-1α neg. NSCLC (down) Suppresses hypoxia-induced proliferation of NSCLC cell [96]
miR-210 NDUFA4, SDHD, PTPN1, TP53I11, HOXA1, HIF-1α pos. NSCLC, NSCLC - late stage (up) Influences cell viability, activates caspase 3/7, promotes double-strand break repair, and increases radioresistance in NSCLC cells. [92, 142, 143]
miR-301b Bim pos. NSCLC specimens and cell lines (up) Enhances cell proliferation, reduces apoptosis, increases resistance to chemotherapy [144]
miR-494 PTEN pos. NSCLC cells (up) Enhances endothelial cell migration, promotes angiogenesis and tumor growth under HOX [97]
miR-519c HIF-1α neg. NSCLC cells (n. d.) Suppresses tumor angiogenesis, growth, and metastasis [145]
miR-622 HIF-1α neg. NSCLC cells (down) Inhibits cancer cell migration and invasion [99]
miR-1908 AKT1S1 n. d. NSCLC (down) Suppresses cell proliferation [146]

HOX, hypoxia; neg., negative; pos., positive; cl., cluster; n. d., non-determined; NSCLC, non-small cell lung carcinoma; CTL, cytotoxic T lymphocytes.